Xerese for the Treatment of Herpes LabialisXerese for the Treatment of Herpes Labialis
What you need to know about Xerese, a topical combination acyclovir-hydrocortisone product for treating herpes labialis, commonly known as cold sores. What other therapies have proven effective? Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 25, 2014 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Link between ritual circumcision procedure and herpes infection in infants examined
(University of Pennsylvania School of Medicine) A rare procedure occasionally performed during Jewish circumcisions that involves direct oral suction is a likely source of herpes simplex virus type 1 transmissions documented in infants between 1988 and 2012, a literature review conducted by Penn Medicine researchers and published online in the Journal of the Pediatric Infectious Diseases Society found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 24, 2014 Category: Global & Universal Source Type: news

Genocea begins Phase II dose optimisation trial for GEN-003 to treat HSV-2
US-based biopharmaceutical firm Genocea Biosciences has initiated a Phase II dose optimisation trial for GEN-003, its immunotherapy candidate for treatment of herpes simplex-type 2 (HSV-2). (Source: Drug Development Technology)
Source: Drug Development Technology - July 22, 2014 Category: Pharmaceuticals Source Type: news

HIV Prophylaxis May Cut Herpes Risk
(MedPage Today) -- Drug therapy to prevent HIV infection also appeared to reduce the risk of catching another virus, herpes simplex 2, among heterosexual men and women, researchers reported. (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - July 1, 2014 Category: Infectious Diseases Source Type: news

Herpes infected humans before they were human
Researchers have identified the evolutionary origins of human herpes simplex virus (HSV) -1 and -2, reporting that the former infected hominids before their evolutionary split from chimpanzees 6 million years ago while the latter jumped from ancient chimpanzees to ancestors of modern humans -- Homo erectus -- approximately 1.6 million years ago. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 11, 2014 Category: Science Source Type: news

Herpes infected humans before they were human
(University of California - San Diego) Researchers at the University of California, San Diego School of Medicine have identified the evolutionary origins of human herpes simplex virus -1 and -2, reporting that the former infected hominids before their evolutionary split from chimpanzees 6 million years ago while the latter jumped from ancient chimpanzees to ancestors of modern humans -- Homo erectus -- approximately 1.6 million years ago. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 10, 2014 Category: Infectious Diseases Source Type: news

Cold Sore Free Forever PDF Review | Discover Derek Shepton’s Methods...
Cold Sore Free Forever PDF designed by Derek Shepton is a newly updated book for people who want to learn how to relieve symptoms of cold sores fast. A full review on the site Vkool.com indicates if...(PRWeb April 22, 2014)Read the full story at http://www.prweb.com/releases/cold-sore-free-forever/review/prweb11778885.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 22, 2014 Category: Pharmaceuticals Source Type: news

Get Rid of Cold Sores Fast Review | Discover Ellie Gadsby’s Home...
Get Rid of Cold Sores Fast designed by Ellie Gadsby is a newly updated program that teaches how to remove cold sore blisters on the lips and face naturally. A full review on the site Vkool.com...(PRWeb April 15, 2014)Read the full story at http://www.prweb.com/releases/get-rid-of-cold-sores/fast-review/prweb11759753.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 16, 2014 Category: Pharmaceuticals Source Type: news

Herpes Simplex Virus Mutant Generation and Dual-Detection Methods for Gaining Insight into Latent/Lytic Cycles In Vivo
Two important components to a useful strategy to examine viral gene regulation in vivo are (1) a highly efficient protocol to generate viral mutants that limits undesired mutation and retains full replication competency in vivo and (2) an efficient system to detect and quantify viral promoter activity in rare cells in vivo. Our strategy and protocols for generating, characterizing, and employing HSV viral promoter/reporter mutants in vivo are provided in this two-part chapter. (Source: Springer protocols feed by Infectious Diseases)
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Modification of HSV-1 to an Oncolytic Virus
Cancer-permissive viruses or oncolytic viruses consist of either genetically engineered or naturally occurring strains that possess relatively selective replicative and/or infection abilities for cancer vs. normal cells (Chiocca, Nat Rev Cancer 2: 938–950, 2002). They can also be armed with additional anticancer cDNAs (e.g., cytokines, prodrug-activating, anti-angiogenesis genes, and others) to extend therapeutic effects (Kaur et al., Curr Gene Ther 9: 341–355, 2009). Herpes simplex virus type 1 (HSV-1) possesses several advantages as an oncolytic virus such as a rapid lytic cycle and a large capacity for inser...
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Engineering HSV-1 Vectors for Gene Therapy
Virus vectors have been employed as gene transfer vehicles for various preclinical and clinical gene therapy applications, and with the approval of Glybera (alipogene tiparvovec) as the first gene therapy product as a standard medical treatment (Yla-Herttuala, Mol Ther 20: 1831–1832, 2013), gene therapy has reached the status of being a part of standard patient care. Replication-competent herpes simplex virus (HSV) vectors that replicate specifically in actively dividing tumor cells have been used in Phase I–III human trials in patients with glioblastoma multiforme, a fatal form of brain cancer, and in malignan...
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Herpes Simplex Virus Type 1 (HSV-1)-Derived Amplicon Vectors
Amplicons are defective, helper-dependent, herpes simplex virus type 1 (HSV-1)-derived vectors. The main interest of these vectors as gene transfer tools stems from the fact that the amplicon vector genomes do not carry protein-encoding viral sequences. Consequently, they are completely safe for the host and nontoxic for the infected cells. Moreover, the complete absence of virus genes provides space to accommodate very large foreign DNA sequences, up to almost 150-kb, the size of the virus genome. This large transgene capacity can be used to deliver complete gene loci, including introns and exons, as well as long regulato...
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Herpes Simplex Virus Growth, Preparation, and Assay
In order to study the biology of herpes simplex virus or to use it as a vector in gene therapy, it is necessary to grow the virus and to prepare virus stocks. Many different protocols are available from different research groups working with herpes simplex virus type 1 or 2 (HSV-1 or HSV-2). This chapter describes the procedures used in our laboratory. (Source: Springer protocols feed by Infectious Diseases)
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Isolation of Herpes Simplex Virus Nucleocapsid DNA
As an inanimate virus, herpes simplex virus type 1 (HSV-1) necessarily encodes all of its functions in its DNA. Isolation of pure viral DNA allows multiple downstream applications, including the creation of recombinant HSV strains, cloning of selected regions, and sequencing of viral DNA. The term nucleocapsid refers to the combination of the viral genome with the enclosing capsid; these viral genomes are necessarily linear and have been packaged for egress, even if they are not yet released from the cell. In contrast, viral DNA that is not associated with capsids may include episomal or concatenated forms and may have mod...
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Construction and Characterization of Bacterial Artificial Chromosomes (BACs) Containing Herpes Simplex Virus Full-Length Genomes
Bacterial artificial chromosomes (BACs) are suitable vectors not only to maintain the large genomes of herpesviruses in Escherichia coli but also to enable the traceless introduction of any mutation using modern tools of bacterial genetics. To clone a herpes simplex virus genome, a BAC replication origin is first introduced into the viral genome by homologous recombination in eukaryotic host cells. As part of their nuclear replication cycle, genomes of herpesviruses circularize and these replication intermediates are then used to transform bacteria. After cloning, the integrity of the recombinant viral genomes is confirmed...
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

HSV-1 Protein Expression Using Recombinant Baculoviruses
The baculovirus expression system is an invaluable method for the expression of Herpes Simplex Virus 1 (HSV-1) proteins. The use of insect cells provides a eukaryotic system for the robust expression of heterologous proteins under control of the baculovirus polyhedrin gene promoter that naturally drives the high expression of the polyhedrin protein. Additionally, insect cells often initiate the necessary posttranslational modifications and/or disulfide-bond formation important for the proper folding of the protein. We and others have successfully expressed and purified several HSV-1 proteins including the polymerase, helic...
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Cryo-EM Techniques to Resolve the Structure of HSV-1 Capsid-Associated Components
Electron cryo-microscopy has become a routine technique to determine the structure of biochemically purified herpes simplex virus capsid particles. This chapter describes the procedures of specimen preparation by cryopreservation; low dose and low temperature imaging in an electron cryo-microscope; and data processing for reconstruction. This methodology has yielded subnanometer resolution structures of the icosahedral capsid shell where α-helices and β-sheets of individual subunits can be recognized. A relaxation of the symmetry in the reconstruction steps allows us to resolve the DNA packaging protein located ...
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

In Vivo HSV-1 DNA Transport Studies Using Murine Retinal Ganglion Cells
We present a method for studying the axonal transport of Herpes simplex virus in mature neurons in situ. Using genetically identical mice and carefully controlling the delivery of virus, an investigator can obtain insight into the transport of virus to and from the neuron cell body within the cellular environment of an intact animal. (Source: Springer protocols feed by Infectious Diseases)
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

HSV-1 Biology and Life Cycle
Herpes simplex virus type 1 (HSV-1) is a common and important human pathogen that has been studied in a wide variety of contexts for several decades. This book presents chapters on protocols on many strands of HSV-1 research that are currently in use in leading laboratories. This chapter gives a brief overview of HSV-1 biology and life cycle, covering basic aspects of the virus and its replication in cultured cells, the diseases caused by the virus, viral latency, antiviral defenses, and the mechanisms that the virus uses to counteract these defenses. (Source: Springer protocols feed by Infectious Diseases)
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Multifluorescence Live Analysis of Herpes Simplex Virus Type-1 Replication
The possibility to label specific viral and cellular structures with live cell markers such as autofluorescent proteins has greatly contributed to our understanding of diverse steps of the virus life cycle, as it allows monitoring virus replication in a spatial and temporal fashion. Here, we describe the multi-fluorescent analysis of the multi-compartment herpes simplex virus type-1 by live-cell confocal laser scanning microscopy. (Source: Springer protocols feed by Infectious Diseases)
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Affinity Purification Combined with Mass Spectrometry to Identify Herpes Simplex Virus Protein–Protein Interactions
The identification and characterization of herpes simplex virus protein interaction complexes are fundamental to understanding the molecular mechanisms governing the replication and pathogenesis of the virus. Recent advances in affinity-based methods, mass spectrometry configurations, and bioinformatics tools have greatly increased the quantity and quality of protein–protein interaction datasets. In this chapter, detailed and reliable methods that can easily be implemented are presented for the identification of protein–protein interactions using cryogenic cell lysis, affinity purification, trypsin digestion, a...
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Preparation of Herpes Simplex Virus-Infected Primary Neurons for Transmission Electron Microscopy
Transmission electron microscopy (TEM) provides the resolution necessary to identify both viruses and subcellular components of cells infected with many types of viruses, including herpes simplex virus. Recognized as a powerful tool in both diagnostic and research-based virology laboratories, TEM has made possible the identification of new viruses and has contributed to the elucidation of virus life cycle and virus–host cell interaction. (Source: Springer protocols feed by Infectious Diseases)
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Characterization of Extracellular HSV-1 Virions by Proteomics
The analysis of herpes simplex virus type 1 mature extracellular virions by proteomics requires highly enriched samples to limit false positives and favor the detection of true components. The protocol described below involves the removal of highly contaminating serum proteins and purification of the virions by a series of differential and density centrifugation steps. In addition, L-particles, which are viral particles devoid of genome and capsid but present in the extracellular milieu, are depleted on Ficoll 400 gradients. As previously reported, the resulting viral particles are free of most contaminants and suitable fo...
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

A Precipitation-Based Assay to Analyze Interactions of Viral Particles with Cytosolic Host Factors
Since viruses are obligate intracellular parasites, viral particles, subviral structures, and viral proteins enlist the support of host proteins to foster intracellular transport, viral gene expression, replication, and evasion from antiviral host responses. We have devised a biochemical in vitro method to analyze specific interactions of cytosolic factors with capsids of herpes simplex virus and to characterize host proteins that specifically coprecipitate with different types of viral particles by immunoblotting, mass spectrometry, and immunoelectron microscopy. (Source: Springer protocols feed by Infectious Diseases)
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Using Homogeneous Primary Neuron Cultures to Study Fundamental Aspects of HSV-1 Latency and Reactivation
We describe a primary neuronal culture system suitable for molecular characterization of herpes simplex virus type 1 (HSV-1) infection, latency, and reactivation. While several alternative models are available, including infections of live animal and explanted ganglia, these are complicated by the presence of multiple cell types, including immune cells, and difficulties in manipulating the neuronal environment. The highly pure neuron culture system described here can be readily manipulated and is ideal for molecular studies that focus exclusively on the relationship between the virus and host neuron, the fundamental unit o...
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Phenotypic and Genotypic Testing of HSV-1 Resistance to Antivirals
Resistance testing of antivirals to herpes simplex virus type 1 can be done by phenotypic and genotypic methods. The determination of a resistant phenotype is based on the calculation of inhibitory concentrations for the antiviral drug, which should be tested. The main advantage is a clear interpretation of laboratory findings, but the method is time consuming and a considerable experience is required for handling infectious virus. Genotypic resistance testing is based on the detection of resistance-related mutations in viral genes encoding the thymidine kinase and DNA polymerase by means of amplification and sequencing. T...
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

What Causes Ataxia?
Discussion Coordination and balance problems are caused by various problems affecting the central and peripheral nervous system. Normal development of a child or weakness of a child are commonly mistaken for true ataxia. Ataxia specifically refers to “…impairment of the coordination of movement without loss of muscle strength.” If it is purely due to abnormalities of the cerebellum then there should be no changes in mental status, sensation or weakness. Sometimes it is difficult to determine if there are abnormalities in other areas. For example, Guillian-Barre often presents with difficulty or clumsy wa...
Source: PediatricEducation.org - March 31, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

HSV-2 vaccine shows significant clinical symptoms & viral shedding reductions at 6 months
(Linnden Communications) Updated Phase 1/2a GEN-003 results, a vaccine candidate under development for the treatment of herpes simplex virus type 2 infection, showed the vaccine generated highly significant reductions in both the number of clinical lesion days and rate of viral shedding at six months after the final vaccine dose. Genocea, a company pioneering novel T cell vaccines and immunotherapies, reported the results from the ongoing trial as an oral presentation at the World Vaccine Congress. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 24, 2014 Category: Global & Universal Source Type: news

Shingles: Can You Get it Again?
In its latest March 2014 survey, polyDNA found that up to 78% of respondents who had a herpes zoster outbreak wanted to know if it was possible to have another. polyDNA reviews the literature on this topic, and recommends Gene-Eden-VIR to target the latent VZV. (Source: Disabled World)
Source: Disabled World - March 23, 2014 Category: Disability Tags: Herpes Simplex Virus Source Type: news

This Week in Infectious Disease: New HSV Drug
(MedPage Today) -- Clinicians and researchers were excited about the potential of a new drug for herpes simplex infection that has a novel mechanism of action, opening the door to combination therapies. (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 17, 2014 Category: Gastroenterology Source Type: news

Pritelivir May Be Effective and Safe Against Genital HerpesPritelivir May Be Effective and Safe Against Genital Herpes
In a proof-of-concept study, researchers have found pritelivir to be safe and effective against genital herpes simplex virus. Medscape Medical News (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - January 16, 2014 Category: OBGYN Tags: Infectious Diseases News Source Type: news

Investigational Herpes Drug Limits Viral Shedding in Phase II Trial (FREE)
By Kelly Young Pritelivir, the first in a new class of drugs (a helicase-primase inhibitor) for herpes simplex virus, effectively suppressed viral shedding and development of genital lesions in an industry-conducted, phase II … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 16, 2014 Category: Primary Care Source Type: news

New Herpes Drug Blocks Viral Shedding (CME/CE)
(MedPage Today) -- An investigational drug with a novel mechanism of action reduced the rate of viral shedding in patients with genital herpes simplex-2 (HSV-2) infection, researchers reported. (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - January 16, 2014 Category: Infectious Diseases Source Type: news

This Week in Infectious Disease: New Tx for HSV?
(MedPage Today) -- The effect of a new approach to treating herpes simplex virus, as well as the risk of complications after a childhood vaccine, are likely to dominate the infectious disease news this week. (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - January 13, 2014 Category: Pediatrics Source Type: news

Atopy May Double the Risk for Herpetic Eye DiseasesAtopy May Double the Risk for Herpetic Eye Diseases
Atopic disease may double the risk for herpes simplex virus ocular disease and herpes zoster ophthalmicus, according to new research. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 30, 2013 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Cold Sores (Nongenital Herpes Simplex Infections)
Title: Cold Sores (Nongenital Herpes Simplex Infections)Category: Diseases and ConditionsCreated: 6/16/1999 7:38:00 PMLast Editorial Review: 12/9/2013 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - December 9, 2013 Category: Dermatology Source Type: news

Scientists present groundbreaking HIV prevention research
(Oak Crest Institute of Science) Researchers at the Oak Crest Institute of Science are making history by proving that it's possible to develop a drug delivery system that has the potential to protect women from sexually transmitted HIV and herpes simplex virus, while at the same time preventing unintended pregnancy. The report in the journal of Antimicrobial Agents and Chemotherapy describes in vivo results from a novel, multipurpose pod-intravaginal ring delivering three antiretroviral drugs in combination with two hormonal contraceptives. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2013 Category: Infectious Diseases Source Type: news

Study: Cold Sores High Risk for Genital Herpes; polyDNA Recommends...
An article published on Drugs.com on October 17 said that today's teens may be at higher risk than ever of contracting genital herpes because fewer numbers are being exposed as children to HSV-1...(PRWeb November 13, 2013)Read the full story at http://www.prweb.com/releases/2013/11/prweb11320619.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 14, 2013 Category: Pharmaceuticals Source Type: news

New technology combining contraception, HIV and herpes simplex virus-2 prevention
CONRAD Head of drug delivery, Meredith Clark, PhD, presented preclinical data on a new intravaginal ring that provides contraception as well as HIV-1 and HSV-2 prevention at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in San Antonio, Texas. This multipurpose prevention technology (MPT) can remain in the vagina for up to 90 days and releases the contraceptive levonorgestrel (LNG) and tenofovir (TFV), an antiretroviral that inhibits HIV and HSV replication in susceptible cells.The CONRAD product development team, in collaboration with Dr. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 14, 2013 Category: Consumer Health News Tags: Sexual Health / STDs Source Type: news

CONRAD presents new technology combining contraception, HIV and herpes simplex virus-2 prevention
(CONRAD) CONRAD Head of drug delivery, Meredith Clark, Ph.D., today presented preclinical data on a new intravaginal ring that provides contraception as well as HIV-1 and HSV-2 prevention at the 2013 American Association of Pharmaceutical Scientists Annual Meeting and Exposition in San Antonio, Texas.CONRAD's deputy director of clinical research, Marianne Callahan, will also present information on MPTs at the International Conference on Family Planning in Addis Ababa, Ethiopia. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 12, 2013 Category: Global & Universal Source Type: news

Declining HSV-1 Seroprevalence Puts Adolescents at Herpes RiskDeclining HSV-1 Seroprevalence Puts Adolescents at Herpes Risk
New data on the seroprevalence of herpes simplex viruses among U.S. adolescents suggests they face a growing risk for genital infections. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 1, 2013 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Herpes Simplex Virus 1 (HSV-1)-Based Vectors
Herpes simplex virus type 1 (HSV-1) is a neurotropic virus displaying several outstanding adaptations to the nervous system, and each of them can be rationally exploited in the design of gene therapy vectors with regard to neurological applications. Replication-competent attenuated vectors are becoming a suitable and powerful tool to eradicate brain tumors, such as malignant gliomas, due to their ability to replicate and spread only within the tumor mass, and have reached Phase II clinical trials in some cases. Replication-incompetent recombinant vectors are nontoxic gene transfer tools that preserve most of the neurotropi...
Source: Springer protocols feed by Neuroscience - October 26, 2013 Category: Neuroscience Source Type: news

Genetic study confirms saga of ancient human migration
A study of the full genetic code of a common human virus offers a dramatic confirmation of the "out-of-Africa" pattern of human migration, which had previously been documented by anthropologists and studies of the human genome. The virus under study, herpes simplex virus type 1 (HSV-1), usually causes nothing more severe than cold sores around the mouth, says Curtis Brandt, a professor of medical microbiology and ophthalmology at the University of Wisconsin-Madison. Brandt is senior author of the study, now online in the journal PLOS ONE... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 23, 2013 Category: Consumer Health News Tags: Genetics Source Type: news

Increasing number of U.S. adolescents lack antibodies to herpes simplex virus type 1
A new study suggests a growing number of U.S. adolescents lack antibodies that may help protect them later in life against an increasingly important cause of genital herpes. Published in The Journal of Infectious Diseases and available online, the findings show that fewer of today's teens have been exposed in their childhood to herpes simplex virus type 1 (HSV-1), a common cause of cold sores, than U.S. adolescents in previous years... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 21, 2013 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Cold Sores: What are the Treatments? polyDNA Answers Survey Questions
In its latest October, 2013 survey, polyDNA found that up to 52% of respondents did not know what treatments are available for a herpes outbreak. polyDNA reviews the scientific literature on this...(PRWeb October 18, 2013)Read the full story at http://www.prweb.com/releases/2013/10/prweb11241932.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 18, 2013 Category: Pharmaceuticals Source Type: news

Today's Teens More Prone to Genital Herpes, Study Suggests
Teens today may be more susceptible to one type of genital herpes infection once they become sexually active than teens in years past, a new study suggests .In the study, adolescents ages 14 to 19 who had their blood tested between 2005 and 2010 were less likely to have antibodies against herpes simplex virus type 1(HSV-1) compared with teens who had their blood tested between 1999 and 2004. (Source: RWJF News Digest - Public Health)
Source: RWJF News Digest - Public Health - October 18, 2013 Category: American Health Source Type: news

Teens more prone to contracting herpes than before, says study
Recent rates of exposure to herpes simplex virus-1 antibodies have dwindled for adolescents, making it easier for them to get STD (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 17, 2013 Category: Consumer Health News Source Type: news

More US teens susceptible to HSV-1 infection, a growing cause of genital herpes
(Infectious Diseases Society of America) A new study suggests a growing number of US adolescents lack antibodies that may help protect them later in life against an increasingly important cause of genital herpes. The findings show that fewer of today's teens have been exposed in their childhood to herpes simplex virus type 1 (HSV-1), a common cause of cold sores, than US adolescents in previous years. Without these antibodies, today's teens may be more susceptible to genital infections also caused by the virus. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 17, 2013 Category: Global & Universal Source Type: news

Study: Herpes Outbreaks Determined by Immune Genes; polyDNA Recommends...
A study published in the medical journal PLoS Pathogens on August 8th, 2013 associates a “genetic mutation and the clinical severity of recurrent cases of HSV-1 infection (cold sores) (1).” polyDNA...(PRWeb October 12, 2013)Read the full story at http://www.prweb.com/releases/2013/10/prweb11222291.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 14, 2013 Category: Pharmaceuticals Source Type: news

How to Heal Cold Sores | “Cold Sore Freedom in 3 Days” Instructs...
Cold Sore Freedom In 3 Days made by Grace Melgarejo is a brand new program that teaches people how to heal cold sores effectively and quickly. A full Cold Sore Freedom In 3 Days on the site...(PRWeb October 08, 2013)Read the full story at http://www.prweb.com/releases/how-to/heal-cold-sores/prweb11200412.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 9, 2013 Category: Pharmaceuticals Source Type: news